Suppr超能文献

第七届国际听神经瘤会议的总结与共识:散发性听神经瘤管理的最新进展

Summary and consensus in 7th International Conference on acoustic neuroma: An update for the management of sporadic acoustic neuromas.

作者信息

Wu Hao, Zhang Liwei, Han Dongyi, Mao Ying, Yang Jun, Wang Zhaoyan, Jia Wang, Zhong Ping, Jia Huan

机构信息

Department of Otolaryngology Head and Neck Surgery, Shanghai Ninth People's Hospital, Shanghai Jiaotong University School of Medicine, Shanghai 200011, China.

Department of Otolaryngology Head and Neck Surgery, Xinhua Hospital Shanghai University School of Medicine, Shanghai 200092, China.

出版信息

World J Otorhinolaryngol Head Neck Surg. 2016 Dec 24;2(4):234-239. doi: 10.1016/j.wjorl.2016.10.002. eCollection 2016 Dec.

Abstract

Sporadic vestibular schwannoma (acoustic neuroma) is a benign tumor arising from cochleovestibular nerve. Nowadays, various specialties and medical centers are treating this disease, and the multidisciplinary collaboration is the trend. In an effort to promote a uniform standard for reporting clinical results, even for treatment indications, the mainly controversies were posed and discussed during the 7th International Conference on acoustic neuroma, and the agreement was summarized by the Committee of this conference. The main symptoms grading and tumor stage should note its name of classification for making them comparable. The goal of the modern managements for vestibular schwannoma is to improve the quality of life with lower mortality, lower morbidity and better neurological function preservation. The experience of surgical team and their preference might be a major factor for the outcome. Because of lacking of long-term follow-up large data after radiotherapy, and with the development of microsurgery, radiotherapy is now less recommended except for recurrent cases or elderly patients.

摘要

散发性前庭神经鞘瘤(听神经瘤)是一种起源于蜗神经前庭支的良性肿瘤。如今,多个专业领域和医疗中心都在治疗这种疾病,多学科协作是发展趋势。为了推动临床结果报告的统一标准,甚至包括治疗指征,在第7届国际听神经瘤会议上提出并讨论了主要争议点,会议委员会总结了达成的共识。主要症状分级和肿瘤分期应注明其分类名称,以便进行比较。现代前庭神经鞘瘤治疗的目标是提高生活质量,降低死亡率、发病率,并更好地保留神经功能。手术团队的经验及其偏好可能是影响治疗结果的主要因素。由于缺乏放疗后的长期随访大数据,且随着显微外科技术的发展,除复发病例或老年患者外,目前较少推荐放疗。

https://cdn.ncbi.nlm.nih.gov/pmc/blobs/82f0/5698531/2bd455331608/gr1.jpg

文献AI研究员

20分钟写一篇综述,助力文献阅读效率提升50倍。

立即体验

用中文搜PubMed

大模型驱动的PubMed中文搜索引擎

马上搜索

文档翻译

学术文献翻译模型,支持多种主流文档格式。

立即体验